Researchers have dramatically reduced the occurrence of seizures in a small group of children with epilepsy, using an existing cancer drug they think might be able to treat up to 1.5 million people with intractable forms of the disease.
In a new study, Texas Children’s Hospital neurologists found that children with a rare, severe type of epilepsy received great benefit from Everolimus, a drug approved for the treatment of kidney and brain tumors. The drug targets faulty signaling in the brain that causes uncontrolled cell growth.
